PATENT CLAIM ANALYSIS

Application Number: 15917263
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["552", "546000"]

Abstract:
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3a , R 3b , R 4 , R 5a , R 5b , R 6a , and R 6b  are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions.

Claim (Index 29):
The compound of  claim 26 , having the structure where the absolute stereochemistry of the compound, including the C-24 carbon atom shown as (R), is as shown.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 90.0
- Lexical Diversity: 1.57447
- Patent Class: 552.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15698151', '15319503', '15143312', '14785192', '15809845']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6852690430901058
- 35 USC 102 Novelty (BERT): 0.619835864020978
- Combined Prediction Score: 0.6787257251831931
- Mean Citation Score: 324.96285
- Max Citation Score: 331.71878
- Similarity Product: 214.369152166667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test